Assessment of Corneal Stability and Visual Outcomes in Myopic Patients in China Two Years After FS-LASIK with Preventive Corneal Crosslinking - Top-Institutions - MDSpire

Assessment of Corneal Stability and Visual Outcomes in Myopic Patients in China Two Years After FS-LASIK with Preventive Corneal Crosslinking

  • By

  • Jiayu Li

  • Yuyan Huang

  • Yushan Xu

  • Zecheng Wang

  • Yanzheng Song

  • Fengju Zhang

  • March 5, 2026

  • 0 min

Share

Top Institutions in Ophthalmology

Brief introduction explaining scope and methodology.

  • #1

    Beijing Tongren Hospital
    Beijing Tongren Hospital

    Beijing, Beijing

    Key Differentiators

    • Ophthalmology
    • Refractive Surgery
    • Corneal Biomechanics

  • #2

    Bascom Palmer Eye Institute, University of Miami
    Bascom Palmer Eye Institute, University of Miami

    Miami, Florida

    Key Differentiators

    • Ophthalmology
    • Corneal Surgery
    • Refractive Surgery

  • #3

    Massachusetts Eye and Ear Infirmary, Harvard Medical School
    Massachusetts Eye and Ear Infirmary, Harvard Medical School

    Boston, Massachusetts

    Key Differentiators

    • Ophthalmology
    • Corneal and External Disease
    • Refractive Surgery

  • #4

    Wills Eye Hospital
    Wills Eye Hospital

    Philadelphia, Pennsylvania

    Key Differentiators

    • Ophthalmology
    • Corneal Surgery
    • Refractive Surgery

Original Source(s)

Assessment of Corneal Stability and Visual Outcomes in Myopic Patients in China Two Years After FS-LASIK with Preventive Corneal Crosslinking

  • by Jiayu Li, Yuyan Huang, Yushan Xu, Zecheng Wang, Yanzheng Song, Fengju Zhang

  • March 5, 2026

Related Content

LaZrPlastique®: Refractive Surgery Beyond the Procedure

“So… LaZrPlastique is not PRK?”

Cataract Surgeons Gain a New Lens Tool

An extended depth of focus intraocular lens approved by the FDA is designed to improve visual range while maintaining contrast sensitivity in cataract surgery.

Is Europe Safe from the Myopia Epidemic?

As global myopia rates soar, three landmark meta-analyses examine the European epidemiological landscape